Arterial hypertension – how to choose therapy rationally? Case report
Article Sidebar
Main Article Content
Abstract
Nowadays, the choice of pharmacotherapy depends not only on the main underlying disease, but also on comorbidities. Thus, patients with arterial hypertension and diabetes are treated differently, as well as those with accompanying cardiac arrhythmias or with kidney diseases. However, does antihypertensive therapy differ from patient to patient if he or she has hypertension “only”? Because of the multitude of therapeutic regimens and numerous representatives of the recommended groups of drugs, it seems most reasonable to select the therapy based not only on comorbidity, but also on the patient’s lifestyle, reported adverse drug reactions, the assumed therapeutic goal or metabolic profile. This was the case with the patient described in the article.
Article Details
Copyright © by Medical Education. All rights reserved.
References
2. Zasady postępowania w nadciśnieniu tętniczym – 2019 rok. Nadciśnienie Tętnicze w Praktyce. 2019; 5(1): 1-84.
3. Gajewski P (ed). Interna Szczeklika 2019. Medycyna Praktyczna, Kraków 2019.
4. Karta ryzyka SCORE dla populacji polskiej (Pol-SCORE 2015). Kardiol Pol. 2015; 73: 958-61.
5. Rekomendacje dotyczące leczenia dyslipidemii w Polsce – III Deklaracja Sopocka. Interdyscyplinarne stanowisko grupy ekspertów. Choroby Serca i Naczyń. 2018; 15(4): 199-210.
6. Głuszek J, Pawlaczyk K. Działania niepożądane antagonistów wapnia. Choroby Serca i Naczyń. 2006; 3(1): 18-31.
7. Mancia G, Coca A, Chazova I et al. Effects on office and home blood pressure of the lercanidipine-enalapril combination in patients with Stage 2 hypertension: a European randomized, controlled clinical trial. J Hypertens. 2014; 32(8): 1700-7.
8. Ghiadoni L, Bruno RM, Cartoni G et al. Combination therapy with lercanidipine and enalapril reduced central blood pressure augmentation in hypertensive patients with metabolic syndrome. Vascul Pharmacol. 2017; 92: 16-21.
9. De Ciuceis C, Salvetti M, Rossini C et al. Effect of antihypertensive treatment on microvascular structure, central blood pressure and oxidative stress in patients with mild essential hypertension. J Hypertens. 2014; 32(3): 565-74.
10. Rump Ch. Efficacy and tolerability of the fixed lercanidipine-enalapril combination in the treatment of patients with essential hypertension. Arzneimittelforschung. 2010; 60(3): 124-30.